This cluster is routine and non-informative. Monitor for upcoming clinical catalysts or financing events, as the company is a pre-revenue biotech with 83% analyst bullishness. The director grants suggest no insider concern about near-term viability.
Price Chart
Executive Summary
A cluster of insider transactions at Century Therapeutics shows a net selling direction, but the total value is only ~$5K, representing approximately 0.001% of the $406M market cap. The only open-market sale is by SVP Carr Douglas for ~$4K; the other sale is a small tax-withholding disposition. The cluster is dominated by non-cash director grants (370K shares awarded at $0) and CEO/CSO tax-withholding events, which carry no economic signal. The dollar amount is trivial relative to company size, and the selling is not concentrated in C-suite executives with material economic exposure.
Key Financial Metrics
Key Facts
- Total insider cluster value is ~$5K, or ~0.001% of $406M market cap — well below the 0.1% materiality threshold.
- Only one open-market sale: SVP Carr Douglas sold 1,654 shares for ~$4K on June 12.
- Five directors received 74,000 shares each in non-cash grants (total 370K shares, $0 value) — routine compensation.
- CEO Pfeiffenberger and CSO Cowan surrendered shares for tax withholding (non-cash, no economic signal).
- No insider open-market purchases were reported in the cluster.
Financial Impact
Trivial — total insider sale value of ~$5K is immaterial for a $406M market cap company.
Risk Factors
- Pre-revenue biotech with no disclosed revenue or pipeline milestones in this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-IPSC-1781567826384 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 2, 2026 24d ago | 8-K | $1.53 $1.48 | ▼ −3.27% | ▼ −3.94% | $1.42 (−7.19%) |
Oct 2, 2026 24d ago | Press Release | $1.53 $1.48 | ▼ −3.27% | ▼ −3.94% | $1.42 (−7.19%) |
Sep 22, 2026 4w ago | Institutional Cluster | $1.89 $1.76 | ▼ −6.88% | ▼ −6.16% | $1.42 (−24.87%) |
Sep 10, 2026 6w ago | 3 | $1.94 $2.00 | ▲ +3.09% | ▲ +3.54% | $1.42 (−26.80%) |
Aug 12, 2026 10w ago | 8-K | $1.96 $1.93 | ▼ −1.53% | ▼ −2.23% | $1.42 (−27.55%) |
Aug 12, 2026 10w ago | Press Release | $1.96 $1.93 | ▲ +1.53% | ▲ +2.23% | $1.42 (+27.55%) |
Jun 16, 2026 18w ago | 8-K | $2.25 $2.29 | ▲ +1.78% | ▲ +1.00% | $1.42 (−36.89%) |
Jun 15, 2026 19w ago | Insider Cluster | $2.18 $2.25 | ▲ +3.21% | ▲ +4.46% | $1.42 (−34.86%) |
Jun 9, 2026 19w ago | Insider Cluster | $2.12 $2.24 | ▲ +5.66% | ▲ +3.96% | $1.42 (−33.02%) |
Jun 9, 2026 19w ago | Insider Cluster | $2.12 $2.24 | ▲ +5.66% | ▲ +3.96% | $1.42 (−33.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers